Key Takeaways
- Shares of Everpure climbed 10% on Monday following a Susquehanna upgrade from Neutral to Positive
- Susquehanna’s new price target of $120, up from $85, suggests approximately 33% potential upside
- Increasing adoption of 2Tb QLC-based high-capacity SSDs is materializing after prolonged delays of nearly 12 months
- Morgan Stanley separately upgraded shares to Overweight, setting a $108 target
- The company reports Q2 FY2027 results on August 26, with analysts expecting $0.58 EPS on $1.1B revenue
Shares of Everpure (P) rallied 10% during early Monday trading hours following a significant upgrade from Susquehanna, which moved its rating from Neutral to Positive while simultaneously boosting its price target to $120 from the previous $85.
This updated price objective represents approximately 33% potential appreciation from the stock’s Friday closing price. Trading commenced Monday morning at $89.92.
According to Susquehanna analyst Mehdi Hosseini, recent supply chain investigations reveal that orders for 2Tb QLC-based, high-capacity solid-state drives are finally gaining momentum after experiencing roughly a year of postponements.
“When combined with Everpure’s expansive and well-diversified product lineup, we believe this development has resulted in a more balanced hyperscaler customer base,” Hosseini noted in his Monday research report.
According to Hosseini’s analysis, this strategic positioning enables the company to capitalize on expanded purchasing of mass-capacity SSDs throughout the latter half of 2026, especially for key-value cache offloading implementations.
Profitability Outlook
Hosseini additionally highlighted enterprise clientele as a supplementary catalyst for expansion, pointing to infrastructure modernization cycles and storage requirements for on-premises AI inference workloads.
Revenue generated from hyperscaler channels generally delivers gross profit margins ranging between 75% and 85%. Everpure’s latest quarterly results, which contained zero hyperscaler product sales, reported a GAAP gross margin of 68.7% alongside an adjusted gross margin of 70.1%.
This indicates that any acceleration in hyperscaler-related sales could deliver substantial margin expansion.
In a separate move on Monday, Morgan Stanley also elevated its stance on Everpure, upgrading from Equal Weight to Overweight while increasing its price objective from $87 to $108.
The overall analyst sentiment leans optimistic. Among 21 analysts tracking the stock, 15 maintain Buy recommendations, five have Hold ratings, and a single analyst rates it as Sell. The average price target stands at $98.30.
Looking Ahead
Everpure is scheduled to release its Q2 FY2027 financial results following market close on August 26. Analyst consensus calls for adjusted earnings per share of $0.58 alongside revenue of $1.1B.
For perspective, the company exceeded projections in its previous quarterly report. It delivered EPS of $0.47 compared to the $0.40 estimate, while revenue reached $1.05B versus the anticipated $997.88M. This represented year-over-year revenue expansion of 35.2%.
A notable development: company insiders have divested $25.8 million in shares during the past 90 days. This figure includes two director-level transactions that occurred in late June.
Institutional stakeholders continue to maintain a substantial presence at 83.42% ownership, with Goldman Sachs expanding its holdings by more than 100% during Q1, acquiring an additional 595,307 shares.
Everpure trades within a 52-week range spanning $54.37 to $100.59, carrying a market capitalization of roughly $29.89 billion.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
